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 Abstract – Polycystic Ovary Syndrome (PCOS) 
is an endocrine disease. PCOS afflicts 5 to 10 % of 
women of reproductive age. The symptoms are: 
amenorrhea, oligomenorrhea, hirsutism, obesity, 
infertility, chronic hyperandrogenic anovulation and 
acne. 
Other risk factors aggravate this condition: insulin 
resistance, obesity, hypertension, dyslipidemia, 
inflammation and subclinical cardiovascular disease. 
Anxiety, depression and reduced quality of life are 
also common. 
This review highlights the mechanisms and the 
beneficial effects of acupuncture, exercise and 
resveratrol on animal models and on humans 
affected by PCOS.  
 




Polycystic Ovary Syndrome (PCOS) is an endocrine 
disease characterized by a still unclear aetiology resulting 
from the interaction among genetic, behavioral and 
environmental conditions and where ovarian 
hyperandrogenemia plays a key role [1].   
Indeed, several studies demonstrate that a low dose of 
testosterone in female monkeys Rhesus increases 
luteinizing hormone (LH) secretion [2, 3, 4, 5]. Further, 
androgens can determine PCOS-like syntomatic pictures 
in animal female and female-to-male transsexual models 
[6]. 
Hyperinsulinemia/insulin resistance and abdominal 
obesity are relevant. However, whether hyperandrogenism 
results from the hyperinsulinemia of insulin resistance or 
vice versa is unclear [7, 8].  Studies performed on 
monkeys, sheep and rats demonstrate that prenatal 
androgenization is a cause of PCOS [9, 10]. In human, 
only one study has verified the presence of testosterone in 
the blood of babies from PCOS mothers [11]. Also the 
exposition to androgens in a prepuberal period causes 
PCOS in animal models [12, 13]. At the begin of ovary 
development, antimůllerian hormone (AMH) is a 
determinant of follicular activity. In rats increased AMH, 
as in PCOS, decreases the follicular growth in ovary [14, 
15] and is linked with low levels of FSH [16, 17]. 
Moreover, as shown from in vitro studies on granulose 
cells of small bovine follicles cultured with testosterone,  
AMH expression  is downregulated and may cause PCOS 
[18]. 
It is known that neuroendocrine defects can increase the 
persistently rapid LH  pulsatility  and this latter have been 
linked with augment of the ovarian volume, several antral 
follicles and androgen hyperproduction [8]. The high 
activity in the sympathetic neurons innervating the ovaries 
precedes the development of ovarian cysts in rats [16]. 
Women with PCOS may have increased ovarian nerve 
fiber density and androgen hypersecretion. Further, the 
high circulating testosterone in PCOS women explains 
their high sympathethic nervous system activity [17] 
associated with several clinical findings illustrated in 
Table 1 [19]. 
 
TABLE 1. SIGNS AND SYMPTOMS OF PCOS CAUSED BY 




  Reprinted with modifications 
from E. Stener-Victorin et 
al. (2008) with permission 
from John Wiley and Sons, 
copyright (2013) License 
Number 3286560319536 
  
    
    
It has been demonstrated that PCOS women have ovarian 
theca interna hyperplasia responsible for the increased 
androgen steroidogenesis. Besides, theca cells have higher 
expression of LH  receptors with augmented sensibility to 
LH stimulation [18, 20, 21 ]. 
GnRH pulse generator is inhibited by the central β-
endorphin system that also modulates sympathetic tone. 
Diminished or augmented β-endorphin and dopamine 
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activity causes tonic increasing release of LH [22, 23]. 
High plasma β-endorphin levels are related to 
hyperinsulinemia, stress [24, 25] and also to PCOS. 
Growth hormone (GH) and insulin growth factor-1 (IGF1) 
regulate sympathetic nerve tone : and in PCOS have been 
shown to be present disturbances in the somatotrophic 
axis (GH/ IGF-1) [26]. Moreover, high sympathetic 
nervous tone is the most relevant risk factor for heart 
diseases and mortality [27, 28]. The effects of these 






                         
 
Fig. 1: Schematic illustration of PCOS events. 









Because PCOS is a multifactorial pathology several 
treatments (see table 2) have been proposed [31]. It is 
demonstrated that cognitive performances (word learning 
test and symbol digit substitution test) are also improved 
significantly after the treatment (Metformin) for PCOS 
[32]. Acupuncture is now widely used in the Western 









Acupuncture is an ancient beneficial practice that use 
needles for manual or electrical sensory stimulation of 
somatic afferent nerves. These nerves innervate the skin 
and muscles. 
Auricular stimulation is widely used to improve 
pregnancy (see table of auricular acupuncture in figure 2). 
Traditional Chinese medicine (TCM) affirmed that 
acupuncture restores the balance between Yin and Yang. 
In the modern interpretation of the Western Medicine, 
acupuncture restores the equilibrium between 
parasympathetic and sympathetic activity [33]. 
 The insertion of needles determines a specific pattern of 
afferent response in peripheral nerves stimulating  the 




Fig.2: Auricular acupuncture. 
Reprinted from Ernest Hung Yu Ng et al. (2008), by permission from 
Elsevier, copyright (2013) License number 3286611228365. 
 
 
Electroacupuncture (EA) takes advantage of a low 
frequency (1-15 Hz) electrical stimulation that elicits 
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muscle contraction and augments the analgesic effects of 
acupuncture [35]. Acupuncture can activate autonomic 
responses (as seen in figure 3), the descending inhibitory 
pain control systems, and the propriospinal 
heterosegmental antinociceptive C-fibers [36, 37] and Aα, 
β, δ fibers [38, 34]. Positive results of this millenary 
treatment for PCOS women is related to: the central  
sympathetic inhibition through a major release of 
endorphin, the change of uterine blood flow and motility, 
the stress reduction. Acupuncture regulates the 
hypothalamic-pituitary-ovarian axis (HPO) actions by 
modulating central opioids, in particular β-endorphin [38, 
39] in a context of mesencephalic and brainstem network 





Fig. 3: EA and autonomic effects. 
Reprinted with modifications from E. Stener-Victorin et al. (2010),  
with permission of Elsevier. copyright (2013), License number 
3286600811085 
 
There are opioid receptors of several types: μ, δ and κ in 
peripheral afferent nerve terminals [42, 43]. β-endorphin 
is a derived from proopiomelanocortin (POMC). It is 
produced in the arcuate nucleus of hypotalamus and in the 
pituitary gland and  binds μ receptors [44, 45, 46]. This 
nervous network is composed by: hypothalamus, medulla 
oblongata, ventrolateral periaqueductal gray, and the 
dorsomedial prefrontal cortex. This functional circuit 
appear to be very important for the autonomic regulation 
[47, 48], in particular for the pain modulation. Further, 
functional MRI and PET
 
studies demonstrate that using 
acupuncture is possible to show significant modulatory 
effects on the limbic system, paralimbic and subcortical 
gray structures [49 , 50, 51, 52, 53, 38]. 
 
An important acupuncture point, used also in PCOS and in 
other disorders, is ST 36 (stomach 36 or Zusanli; shown in 
figure 4) on the lower leg .  
 
 
Fig. 4: localization of ST36 in the tibialis anterior muscle, 4 
fingerbreadths below the kneecap and 1 fingerbreadth 
lateral from the anterior crest of the tibia [54]. 
Reprinted from Kathleen K.S. Hui et al. (2005), by permission from 
Elsevier, copyright (2013) License number 3286610770603 
 
When it is stimulated, fRMN  shows a predominance of 
signal attenuation, particularly in the limbic/paralimbic 
regions of the telencephalon, diencephalon and brainstem 
[50, 51, 53].  
This evidences an integrated response of the human 
cerebro-cerebellar and limbic systems to acupuncture 
treatment. As shown also in rats models, after 
acupuncture, fRMN and PET results indicate an integrated 
response from multiple functional units of the brain which 
appear to be dependent on the psychophysical status . 
Moreover, the hemodynamic response correlates with 
acupuncture effects on the monoaminergic systems. 
Maybe these neuromodulators, in particular dopamine, 
may play an important role in acupuncture actions [54]. 
Another important beneficial effect of acupuncture is 
related to the actions on the corticotrophin releasing 
hormone (CRH) produced by the hypothalamus. 
β-endorphin and reproductive functions are linked to 
GnRH and LH release.  
Estrogens are important to ovulate for the LH surge [55] 
and opioids inhibits the effect of estrogens [56]. 
CRH is released under stress conditions and decreases 
GnRH secretion. Acupuncture decreases the levels of 
CRH and modulate the HPO and HPA axis [57].  
Moreover, acupuncture have been shown to increase 
glucose uptake and microcirculation [58, 59].  
Needles stimulations decrease sympathetic activity and 
increase parasympathetic activity inhibiting the 
dorsomedial prefrontal cortex [60]. Peripheral nerves 
release neuropeptides: neuropeptide Y (NPY), vasoactive 
intestinal polypeptide (VIP), substance P and calcitonin 
gene-related peptide (CGRP) with a rapid reaction [61, 
62]. 
EA stimulates enkephalinergic neurons in the brain areas 
that regulates sympathetic outflow [63, 64]. 
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According to these results, Li et al. [65] found that a 
single brief acupuncture stimulation at points P5-P6 
transiently induces the production of enkephalin 
associated with a brain regulation of the sympathetic 
outflow.  
Consequently, acupuncture may control the hypothalamic-
pituitary-adrenal (HPA) axis (diminishing cortisol 
concentrations) and the hypothalamic-pituitary- gonadal 
(HPG) axis (modulating central 𝛽-endorphin production 
and secretion) [66]. EA controls the symphatetic reflex 
responses by decreasing the release of GABA in the 
ventrolateral periaqueductal gray ( vlPAG) [67]. The 
decrease of GABA disinhibits vlPAG cells. This action  
modulates the activity of rostral ventrolateral medulla 
(rVLM) neurons attenuating  the sympathoexcitatory 
reflex responses [68]. Probably, both glutamate and 
GABA are involved in the mechanism of acupuncture 
modulation of autonomic response.  
Moreover, EA could give benefits to  PCOS and other 
metabolic disorders, by altering sympathetic signaling  
[69, 70]. EA reduces mRNA
NGF 
 in dihydrotestosterone 
(DHT) -induced rats and also
  
in estradiol-valerate – (EV-) 
induced rats which have been used as PCOS models [71]. 
Nerve growth factor (NGF) is, in fact,  higher in PCOS 
women ovaries and in EV-induced rats PCOS models  
[72, 73, 74]. NGF arrests follicle growth,  augments 
ovarian sensibility to gonadotropins, increases adrenergic 
receptors  and it causes ovarian hyperinnervation in 
transgenic mice models generated by pronuclear 
microinjection of the transgene construct into fertilized 
eggs from B6D2F1/J mice followed by transfer of the 
injected eggs into the uterus of a surrogate mother [72]. 
The decrease of NGF expression in peripheral organs 
could improve EA by modulating the autonomic nervous 
system activity [75]. In rats, EA decreases circulating 
testosterone concentrations and modulate the expression 
of opioid receptors μ and κ in the hypothalamus [76]. 
Furthermore, acupuncture in rats normalizes estrous 
cyclicity [76, 77], improves ovarian morphology [70], 
reduces circulating concentrations of inhibin B [78] and 
increases progesterone levels [76].  
 
 
2. PHYSICAL ACTIVITY AND 
RESVERATROL 
As shown in the figure 1, PCOS is characterized by lipidic 
blood profile, bigger adipocytes and insulin resistance.  
These alterations determine visceral obesity and 
hypertension [79, 80]. Insulin resistance in skeletal 
muscles is related to alterations in fatty acid metabolism 
and mitochondrial abnormalities. In PCOS women it is 
associated with reduced gene expression of peroxisome 
proliferator-activated receptor 𝛾 coactivator 𝛼 (PGC-1𝛼) 
and sirtuins (SIRT) 1 and 3 [81, 82].  
Resveratrol, a natural polyphenol, may have positive 
metabolic effects. It balances lipid profile, decreases 
adiposity and improves insulin sensitivity [83]. 
Resveratrol increases, in skeletal muscle, the mRNA 
levels of estrogen-related receptor 𝛼 (Erra), PGC-1𝛼, and 
the ERR𝛼/PGC-1𝛼 signaling pathway target gene 
expression of nuclear respiratory factor 1 (Nrf1) (all 
decreased in PCOS) [84, 85]. 
Resveratrol causes apoptosis and diminishes proliferation 
of rat theca cells, reduces androgen levels by arresting 
Cyp17a1 gene expression [86, 87]. Some of these results 
are linked to the activation of SIRT 1 [88]. Resveratrol  
can activate AMP-activated protein kinase (AMPK) using 
a cAMP signaling and mediates glucose transporter 
(GLUT)-4 translocation and higher glucose uptake [89]. 
High leptin levels inhibit ovulation in rats [90] : this 
polyphenol combined to physical activitity reduce fat 
mass and also leptin [69, 91 ]. Moreover,  
physical activity  and somministration of resveratrol 
improve estrus cyclicity in PCOS rats [92]. The study by 
A. Benrick et al. by treating PCOS rats with resveratrol 
demonstrates that  resveratrol has beneficial effects on 
adiposity (that improves) and cyclicity in a similar manner 
to exercise, but  it is not a good candidate for treating 
insulin resistance associated with PCOS [92]. 
Moreover, physical activity and acupuncture decrease 
high muscle sympathetic nerve activity in women affected 
by PCOS. It is also demonstrated that acupuncture is more 
effective than physical exercises [18,93]. Physical 
activities determine weight loss improving cardiovascular 
order and insulin cellular response; visceral adiposity and 
insulin response (IR) decrease [94, 95].  
Regular and moderate aerobic exercises (90 min per week 
at 60-70 % VO2max) over a short period  improve 
ovulation and menstrual frequency  [96, 97].  
 
                            III.RESULTS 
 
Goal of these review is to make a transactional correlation 
between the results obtained in PCOS animal models and 
human using acupuncture, physical activities and 
resveratrol. In the tables 3, 4 and 5 some of the 
experiments performed in this field are compared.  
 
TABLE 3: EFFECTS OF ACUPUNCURE ON RODENTS MODELS 
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TABLE 5: EFFECTS OF RESVERATROL AND EXERCISE ON  






In the experiment no.1 Manni et al. demonstrated 
that repeated low-frequency EA treatments modulate 
the expression of mRNA and the amount and 
distribution of proteins of α1-, and β2- 
adrenoreceptors (ARs), and of p75NTR in rats with 
steroid-induced PCOS [71].  
In the study no.2 electrical and manual muscle 
stimulation affect glucose homeostasis through 
different mechanisms in rats with DHT induced 
PCOS. Manual stimulation improved whole-body 
glucose tolerance, an effect that was not observed 
after electrical stimulation, but did not affect 
molecular signaling pathways to the same extent as 
electrical stimulation. Although more functional 
signaling pathways related to insulin sensitivity were 
affected by electrical stimulation, maybe manual 
stimulation of acupuncture has a greater effect on 
glucose tolerance [78]. 
In the experiment no.3 E. Stener-Victorin et al. 
demonstrated high sympathetic activity in PCOS 
model rats and its decrease after EA treatment [73] . 
In the study  no.4 Johansson et al. addressed 
acupuncture as a potential treatment option  in 
women with PCOS. Several studies indicated in fact 
that acupuncture is beneficial for ovulatory 
dysfunction in PCOS. This is also related to 
decreased levels of sex steroids and inhibin B. 
Although the  clinical data does not support changes 
in LH pulsatility/secretion pattern as a possible 
mediator for this effect, there is strong evidence of 
central components that probably involve both 
opioid and sympathetic activities, an effect that may 
be mediated via the androgen receptor [78]. 
 In the experiment no.5 Stener-Victorin et al. 
demonstrated that the mean pulsatility index (PI) of 
uterine vessels was significantly reduced shortly 
after electroacupuncture. This may improve the 
endometrial environment for embryo implantation 
[73] . 
In the study no.6 A.  Benrick at al. performed a 5-6 
weeks  resveratrol treatment on PCOS rats and did 
not find improvements in insulin sensitivity in DHT-
induced PCOS rats, while exercise restored insulin 
sensitivity to a similar level as in control rats. 
Physical exercise also had beneficial effects on fat 
mass, adipocyte size, and estrus cyclicity [92]. 
In the experiment no. 7, it is evidenced that  low-
frequency EA and physical exercise decrease high 
sympathetic nerve activity in women with PCOS. 
Thus, since muscle sympathetic nerve activity 
(MSNA) can  increase the cardiovascular risk, 
treatment with low-frequency EA or physical 
exercise aimed to reduce MSNA may be of 
importance for women with PCOS [98]. 
The effects of acupuncture on NGF expression are 
summarised in figure 5 [71, 73, 74, 99].  
 
 
V.  CONCLUSION 
 
Several studies confirmed that acupuncture, physical 
activity and (to a lesser extent) resveratrol may 
improve metabolic, hormonal and psychological 
profile of PCOS in women. These positive results 
have been shown also in animal models, underlying 
the importance of these treatments, and their 
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Fig. 5 Neurophysiological effects of acupuncture (A), EA (B) and 
physical activity (C)  in rats affected by estradiol-induced polycystic 
ovaries                  
(A) Reprinted with modifications from Franconi et al. (2011), copyright 
(2011) with permission from Editrice Kurtis s.r.l.; 
(B) parts of this figure were originally published in Stener-Victorin et al. 
(2003);  
(C) part of this figure was originally published in L. Manni Ph.D. thesis 
(ISBN: 91-628-6484-X). 
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